US FDA says 100 preliminary reports of Guillain-Barre syndrome from J&J vaccine
The FDA in the US says there have been 100 preliminary reports of Guillain-Barre syndrome from 12.8m doses administered of the JNJ vaccine
" FDA said.
"Although the available evidence suggests an association between the Janssen vaccine and increased risk of GBS, it is insufficient to establish a causal relationship
"Available data do not show a similar pattern